Now Available: Final Rule for FDAAA 801 and NIH Policy on Clinical Trial Reporting

Tandospirone Citrate in the Treatment of Patients With Generalized Anxiety Disorder (TACGAD)

This study is currently recruiting participants. (see Contacts and Locations)
Verified October 2016 by Sumitomo Pharmaceutical (Suzhou) Co., Ltd.
Information provided by (Responsible Party):
Sumitomo Pharmaceutical (Suzhou) Co., Ltd. Identifier:
First received: November 11, 2011
Last updated: October 13, 2016
Last verified: October 2016
No Study Results Posted on for this Study
  Study Status: This study is currently recruiting participants.
  Estimated Study Completion Date: December 2017
  Estimated Primary Completion Date: December 2016 (Final data collection date for primary outcome measure)